CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 82.67% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money
11.12
3.39%
Market Trading Hours* (UTC) Opens on Friday at 14:30

Mon - Fri: 14:30 - 21:00

  • Summary
  • Historical Data
Trading сonditions
Spread 0.11
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.024262 %
Charges from full value of position ($-4.61)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.024262%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.00204 %
Charges from full value of position ($0.39)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.00204%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5.00%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 11.51
Open 11.42
1-Year Change -50.11%
Day's Range 11.11 - 11.44
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Dec 11, 2024 11.51 -0.21 -1.79% 11.72 11.73 11.51
Dec 10, 2024 11.72 -0.23 -1.92% 11.95 12.08 11.50
Dec 9, 2024 12.04 0.08 0.67% 11.96 12.29 11.74
Dec 6, 2024 11.91 0.17 1.45% 11.74 12.07 11.63
Dec 5, 2024 11.63 -1.14 -8.93% 12.77 12.80 11.58
Dec 4, 2024 12.74 1.27 11.07% 11.47 12.95 11.27
Dec 3, 2024 11.75 -0.50 -4.08% 12.25 12.46 11.74
Dec 2, 2024 12.48 0.31 2.55% 12.17 12.67 12.17
Nov 29, 2024 12.30 0.08 0.65% 12.22 12.43 12.15
Nov 27, 2024 12.42 0.57 4.81% 11.85 12.47 11.85
Nov 26, 2024 12.03 -0.25 -2.04% 12.28 12.49 11.99
Nov 25, 2024 12.39 0.64 5.45% 11.75 12.57 11.72
Nov 22, 2024 11.70 0.06 0.52% 11.64 12.08 11.50
Nov 21, 2024 11.67 0.60 5.42% 11.07 11.75 10.73
Nov 20, 2024 10.98 0.01 0.09% 10.97 11.15 10.82
Nov 19, 2024 11.01 0.04 0.36% 10.97 11.39 10.89
Nov 18, 2024 11.15 -0.17 -1.50% 11.32 11.60 10.97
Nov 15, 2024 11.41 -0.32 -2.73% 11.73 11.81 11.18
Nov 14, 2024 11.88 -0.24 -1.98% 12.12 12.39 11.47
Nov 13, 2024 12.36 -2.50 -16.82% 14.86 15.17 12.01

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 3:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Quanterix Company profile

About Quanterix Corp

Quanterix Corporation is a life sciences company. The Company is engaged in developing ultra-sensitive digital immunoassay platforms that advance precision health for life sciences research and diagnostics. Its platforms are based on its digital Simoa detection technology. Its Simoa bead-based and planar array platforms enable customers to reliably detect protein biomarkers at extremely low concentrations in blood, serum and other fluids. Its products include HD-X Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, and 2470 Arrayer. It also supplies NF-Light antibodies and ELISA kits, which offer solutions for the detection of neurofilament light (Nf-L) for the development of therapeutics and diagnostics for neurodegenerative conditions. Its portfolio of available kits spans multiple therapeutic areas, including cardiology, infectious disease, inflammation, neurology, and oncology. It provides services through its Simoa Accelerator Laboratory.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Quanterix Corp revenues increased 28% to $110.6M. Net loss increased 83% to $57.7M. Revenues reflect Product revenue segment increase of 84% to $81.1M. Higher net loss reflects Selling, General & Administrative Expens increase of 55% to $79M (expense), Research & Development Expense - Balanci increase of 37% to $26.2M (expense).

Industry: Advanced Medical Equipment & Technology (NEC)

900 Middlesex Turnpike
BILLERICA
MASSACHUSETTS 01821
US

People also watch

BTC/USD

100,049.90 Price
-1.640% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 50.00

Gold

2,681.75 Price
-1.330% 1D Chg, %
Long position overnight fee -0.0160%
Short position overnight fee 0.0078%
Overnight fee time 22:00 (UTC)
Spread 0.30

XRP/USD

2.34 Price
-4.080% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 0.01169

Oil - Crude

69.63 Price
-0.560% 1D Chg, %
Long position overnight fee 0.0084%
Short position overnight fee -0.0304%
Overnight fee time 22:00 (UTC)
Spread 0.030

Still looking for a broker you can trust?

Join the 660,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading